Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells

被引:13
作者
Shih, SJ [1 ]
Erbele, T [1 ]
Chen, AY [1 ]
机构
[1] Univ Calif Davis, Med Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA
关键词
D O I
10.1158/0008-5472.CAN-05-2387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ku86 is an integral component of the nonhomologous end-joining (NHEJ) pathway of cellular double-strand break repair. In the current study, we investigated the role of Ku86 in DNA topoisomerase I-mediated radiosensitization induced by camptothecin in mammalian cells. Interestingly, as examined by clonogenic survival assay, a 30-minute camptothecin treatment induced significantly higher levels of radiosensitization in the Ku86-deficient Chinese hamster ovary xrs-6 cells than in the hamster Ku86-complemented xrs-6+hamKu86 cells, albeit exhibiting similar drug toxicity in these two cell lines. To confirm these findings, similar studies were conducted in two pairs of transfectant sublines established from the Ku86-deficient Chinese hamster lung fibroblast XB-V15B cells. Compared with the vector-alone sublines, radiation resistance was restored in the human Ku86-complemented sublines without alteration of cell cycle distributions. Again, significantly higher levels of camptothecin-induced radiosensitization were observed in the vector-alone sublines than in the Ku86-complemented XR-V15B sublines. In contrast, camptothecin treatments, ranging from 0.5 to 24 hours, induced similar cytotoxicities in both vector-alone and Ku86-complemented sublines. Because neither the DNA-damaging etoposide and cisplatin nor the tubulin-binder vinblastine induced enhanced levels of radiosensitization in the Ku86-deficient cells, Ku86 seems to uniquely affect topoisomerase I-mediated radiosensitization induced by camptothecin. Furthermore, co-treatment with DNA replication inhibitor aphidicolin abolished both camptothecin-induced cytotoxicity and radiosensitization in the vector-alone, as well as the Ku86-complemented subline cells, indicating both events are initiated by replication-dependent topoisomerase I-mediated DNA damages. Taken together, our data show a novel role of Ku86 in modulating topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
引用
收藏
页码:9194 / 9199
页数:6
相关论文
共 20 条
[1]   Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells - Implications for the repair of topoisomerase I-mediated DNA damage [J].
Adachi, N ;
So, SR ;
Koyama, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (36) :37343-37348
[2]  
Chen AY, 1997, CANCER RES, V57, P1529
[3]  
Chen AY, 2004, MOL PHARMACOL, V66, P553
[4]   Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs [J].
Chen, AY ;
Chou, R ;
Shih, SJ ;
Lau, D ;
Gandara, D .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (02) :111-119
[5]  
Chen AY, 2000, ANN NY ACAD SCI, V922, P298
[6]   DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS [J].
CHEN, AY ;
LIU, LF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :191-218
[7]   Hippocampal neurons of mice deficient in DNA-dependent protein kinase exhibit increased vulnerability to DNA damage, oxidative stress and excitotoxicity [J].
Culmsee, C ;
Bondada, S ;
Mattson, MP .
MOLECULAR BRAIN RESEARCH, 2001, 87 (02) :257-262
[8]  
DARPA P, 1990, CANCER RES, V50, P6919
[9]   Ku, a DNA repair protein with multiple cellular functions? [J].
Featherstone, C ;
Jackson, SP .
MUTATION RESEARCH-DNA REPAIR, 1999, 434 (01) :3-15
[10]  
HOLM C, 1989, CANCER RES, V49, P6365